|
|
|
Insider
Information: |
Kingsley Alfred D |
Relationship: |
Director |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
5,968,356 |
|
Indirect Shares
|
1,512,809 |
|
|
Direct
Value |
$5,137,134 |
|
|
Indirect Value
|
$1,323,637 |
|
|
Total
Shares |
7,481,165 |
|
|
Total
Value |
$6,460,771 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
3
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
3
|
0
|
|
|
|
Gain/Loss Ratio : |
-3.0
|
3.0
|
Percentage
Gain/Loss : |
-38.5%
|
148.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
Director |
2021-06-22 |
5,470,245 |
2021-06-22 |
1,418,697 |
Premium* |
|
Asterias Biotherapeutics Inc |
AST |
Director |
2016-06-09 |
9,000 |
2015-06-25 |
0 |
Premium* |
|
Oncocyte Corp |
OCX |
Director |
2023-06-23 |
489,111 |
2023-06-23 |
94,112 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
84 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
|
2003-10-08 |
4 |
A |
$0.00 |
$0 |
I/I |
80,000 |
814,460 |
|
- |
|
LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
|
2004-01-21 |
4/A |
OE |
$1.40 |
$544,662 |
D/D |
389,044 |
2,277,753 |
|
- |
|
LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
|
2004-01-21 |
4/A |
OE |
$1.40 |
$547,567 |
D/D |
391,119 |
2,279,828 |
|
- |
|
LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
|
2004-01-21 |
4 |
OE |
$1.40 |
$363,108 |
D/D |
259,363 |
2,148,072 |
|
- |
|
LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
|
2004-02-05 |
5 |
A |
$1.40 |
$818,181 |
D/D |
584,415 |
2,864,243 |
0 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
|
2004-11-02 |
4 |
A |
$0.00 |
$0 |
I/I |
60,000 |
1,059,670 |
|
- |
|
LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
|
2005-07-14 |
4 |
B |
$0.41 |
$16,400 |
D/D |
40,000 |
2,904,243 |
2.44 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
|
2005-07-20 |
4 |
B |
$0.42 |
$8,400 |
D/D |
20,000 |
2,924,243 |
2.44 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
officerTitle |
|
2005-12-21 |
4 |
OE |
$0.40 |
$534,778 |
D/D |
1,336,946 |
4,261,189 |
|
- |
|
LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
|
2006-04-12 |
4 |
A |
$0.00 |
$0 |
D/D |
33,333 |
4,294,522 |
|
- |
|
LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
|
2006-05-05 |
4 |
B |
$0.28 |
$48,625 |
D/D |
175,000 |
4,469,522 |
2.44 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
|
2006-06-07 |
4 |
B |
$0.24 |
$8,160 |
D/D |
34,000 |
4,503,522 |
2.44 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
|
2006-06-08 |
4 |
B |
$0.24 |
$76 |
D/D |
315 |
4,516,719 |
2.36 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
|
2006-06-13 |
4 |
B |
$0.24 |
$1,196 |
D/D |
4,982 |
4,516,719 |
2.36 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
|
2006-06-14 |
4 |
B |
$0.24 |
$576 |
D/D |
2,400 |
4,516,719 |
2.36 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
|
2006-06-15 |
4 |
B |
$0.24 |
$1,320 |
D/D |
5,500 |
4,516,719 |
2.36 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
|
2006-06-20 |
4 |
B |
$0.24 |
$11 |
D/D |
45 |
4,569,522 |
2.36 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
|
2006-06-22 |
4 |
B |
$0.24 |
$17 |
D/D |
72 |
4,569,522 |
2.36 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
|
2006-06-23 |
4 |
B |
$0.24 |
$276 |
D/D |
1,150 |
4,569,522 |
2.36 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
|
2006-06-26 |
4 |
B |
$0.24 |
$12,369 |
D/D |
51,536 |
4,569,522 |
2.44 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
|
2006-08-11 |
4 |
A |
$0.20 |
$800 |
D/D |
4,000 |
4,573,522 |
|
- |
|
LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
|
2006-08-14 |
4 |
A |
$0.20 |
$60 |
D/D |
300 |
4,573,822 |
|
- |
|
LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
|
2006-08-15 |
4 |
A |
$0.20 |
$1,151 |
D/D |
5,755 |
4,579,577 |
|
- |
|
LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
|
2006-08-18 |
4 |
A |
$0.20 |
$20 |
D/D |
100 |
4,579,677 |
|
- |
|
LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
|
2006-08-21 |
4 |
A |
$0.20 |
$67 |
D/D |
333 |
4,580,010 |
|
- |
|
84 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|